IN THIS SECOND book of The Scenturion Spy series, Dr. Milt Davidson has been recruited from the Empire State University (ESU) in New York, where he is an academic pathologist, to spy for the CIA. Since the Russians are developing bioweaponry based on odors that activate receptors in the nose and affect the brain, Milt - who completed graduate studies for a Ph.D.-degree on the sense of smell (olfaction) while in medical school - developed a biotechnology company (Pharmascent Sciences, Inc.) for new neurological therapies administered via smell. This became his cover to spy on Russia's military's research on olfaction after taking a sabbatical leave from ESU to work for the CIA.
Milt - 43-year-old, handsome, smart, single, and unexpectedly suave for a scientist - gets involved with a French/Israeli spy, Marie Chalfont, as well as Dr. Natasha Petrushkin, a deputy science minister in the Russian parliament. Both help him settle in Moscow, seduce him, and are suspected of being double-agents. The book begins with Milt secretly escaping to St. Martin, where Marie is hiding from the Hezbollah, having assassinated one of their leaders. In Moscow, Milt spies on the Russian olfactory bioweaponry research program through both scientific pretexts and some seduction tactics of his own.
Will Milt uncover major secrets of the Russian bioweaponry program? Or will his cover be blown, and American security threatened? Readers will find out soon enough in this thrilling page-turner.
David Goldenberg, MD, a recognized leader in the field of cancer research, has written an absorbing and exciting novel encompassing his extensive scientific knowledge and a rich imagination in the area of global spying.
Romance and intrigue keep the reader wondering how this scientist, traveling between Russia, New York and Israel, is going to manage his scientific endeavors and complicated love entanglements. All seem to blend, if not seamlessly, then at least without too many hiccups. Murder and a surprise ending makes for a good, interesting read! I recommend it.
- Ruthi Zinn Byrne
Zinn Graves & Field
Marketing & Public Relations
Florham Park NJ 07932
Author Biography:
David M. Goldenberg, Sc.D., M.D., spent 60 years conducting cancer research and was a medical school professor who founded two cancer centers as well as Immunomedics, Inc. He directed the development of Trodelvy(R), an antibody-drug combination approved by the U.S. FDA and several foreign health authorities for the treatment of certain advanced cancers. The sense of smell, the focus on this novel, stems from his studies at the Universities of Erlangen and Heidelberg in Germany, after graduating with an S.B. from the University of Chicago.
